The content is available as a PDF (154.7 KB).
Bibliografía
- 1.Oms Arias M., Morral Parente R.M. ¿Están indicados los COX-2 en pacientes de riesgo? Aten Primaria. 2002;29:230–232. doi: 10.1016/S0212-6567(02)70549-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A. Gastrointestinal toxicity with celecoxib us nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid artritis. The CLASS study: a randomized controlled trial. JAMA. 2000;284:1247–1255. doi: 10.1001/jama.284.10.1247. [DOI] [PubMed] [Google Scholar]
- 3.Singh G., Goldstein J., Bensen W., Agrawal N., Eisen G., Fort J. Success 1 in osteoarthritis (OA) trial. Celecoxib significantly reduces risk of serious upper G-I complications compared to NSAIDs while providing similar efficacy in 13,274 randomized patients [Eular abstracts 2001] Ann Rheum Dis. 2001;60(Suppl 1):58. [Google Scholar]
- 4.Goldstein J.L., Eisen G.M., Stenson W., Agrawal N., Durham N.C., Bello A.E. Significant reduction in serious upper gastrointestinal (UGI) events with celecoxib, a COX-2 specific inhibitor, compared with conventional NSAIDs.The SUCCESS I trial. Gastroenterology. 2001;120(Suppl 1):A105. [Google Scholar]
- 5.Lai K.C., Chu K.M., Hui W.M., Wong C.Y., Hu W., Yuen W.M. COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDs. Gastroenterology. 2001;120(Suppl1):A104. [Google Scholar]
- 6.Chen F.K.L., Leung W.K., Suen B.Y., Lee K., Lee Y.T., Wu J.C.Y. A double-blinded randomized comparison of celecoxib versus omeprazole and diclofenac for secondary prevention of ulcer bleeding in chronic NSAID. Gastroenterology. 2001;120(Suppl 1):A143. [Google Scholar]
- 7.Martin R.M., Biswas P., Mann R.D. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study. Br J Clin Pharmacol. 2000;50:35–42. doi: 10.1046/j.1365-2125.2000.00229.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Singh G., Rosen R.D. NSAID indiced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism and Aging Medical Information System. J Rheumatol. 1998;25(Suppl 51):8–16. [PubMed] [Google Scholar]